|
Vaccine Detail
ProQuad |
Vaccine Information |
- Product Name: Measles, Mumps, Rubella and Varicella Virus Vaccine Live
- Tradename: ProQuad
- Manufacturer: Merck & Co, Inc.
- Vaccine Ontology ID: VO_0000091
- CDC CVX code: 94
- Type: Live, attenuated vaccine
- Status: Licensed
- Location Licensed: USA (License #0002)
- Host Species for Licensed Use: Human
- Preparation: propagated in chick embryo cell culture.
- Immunization Route: Intramuscular injection (i.m.)
- Storage: maintained at a temperature of 2° to 8°C (36° to 46°F) or colder.
- Approved Age for Licensed Use: 12 months to 12 years old
- Contraindication: Vaccine should not be administered to anyone with a known history of anaphylactic reactions to neomycin, or to anyone with a history of hypersensitivity to gelatin or any other component of the vaccine (FDA: ProQuad).
- Description: ProQuad is a sterile lyophilized preparation of (1) the components of M-M-R*II (Measles, Mumps and Rubella Virus Vaccine Live): Measles Virus Vaccine Live, a more attenuated line of measles virus, derived from Enders' attenuated Edmonston strain and propagated in chick embryo cell culture; Mumps Virus Vaccine Live, the Jeryl Lynn™ (B level) strain of mumps virus propagated in chick embryo cell culture; Rubella Virus Vaccine Live, the Wistar RA 27/3 strain of live attenuated rubella virus propagated in WI-38 human diploid lung fibroblasts; and (2) Varicella Virus Vaccine Live (Oka/Merck) refrigerator-stable formulation, the Oka/Merck strain of varicella-zoster virus propagated in MRC-5 cells (FDA: ProQuad).
|
Host Response |
Human Response
- Immune Response: According to clinical trials, there were high levels of antibodies in 98.9% of those vaccinated after a single dose of Proquad (FDA: ProQuad).
- Side Effects: Side effects of vaccination include: injection site reactions, fever, irritability and diarrhea.
|
References |
FDA: ProQuad: FDA: ProQuad Vaccine [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094051.htm]
|
|